您现在的位置: 首页   -  产品中心   -  免疫学   -   抗体
Mouse Anti-Human CD3ε Antibody (S-R531)

Mouse Anti-Human CD3ε Antibody (S-R531)

货号: S0B1007
价格: 600
规格: 25μl
介绍: -
其他: -
产品规格
  • 宿主来源

    Mouse
  • 抗原名称

    CD3
  • 分子别名

    T-cell surface antigen T3/Leu-4 epsilon chain; CD3e; T3E
  • 细胞定位

    Cell membrane
  • Accession

    P07766
  • 克隆号

    S-R531
  • 抗体类型

    Mouse mAb
  • 抗体同种型

    IgG2a
  • 应用

    FCM
  • 反应种属 ?

    Hu
  • 阳性样本

    human PBMC
  • 预测反应种属
    (反应种属缩写表)

    Gor, Pr, Cz, Or, Bv, Sh, Rt, Ct, Rb, Dg, De, Hdg, Bb, Hr, Ms
  • 纯化方式

    Protein A
  • 浓度

    2 mg/ml
  • 标记

    Unconjugated
  • 性状

    Liquid
  • 缓冲体系

    PBS pH7.4

  • 储存条件

    12 months from date of receipt / reconstitution, 2 to 8 °C as supplied

稀释度
应用 稀释度 推荐种属
FCM 1:2000 Hu
背景介绍
  • CD3 (cluster of differentiation 3) is a protein complex and T cell co-receptor that is involved in activating both the cytotoxic T cell (CD8+ naive T cells) and T helper cells (CD4+ naive T cells). It is composed of four distinct chains. In mammals, the complex contains a CD3γ chain, a CD3δ chain, and two CD3ε chains. These chains associate with the T-cell receptor (TCR) and the CD3-zeta (ζ-chain) to generate an activation signal in T lymphocytes. The TCR, CD3-zeta, and the other CD3 molecules together constitute the TCR complex. The CD3–T cell receptor (TCR) complex plays a central role in the T-cell-mediated immunoresponse as it is involved in the recognition of antigens and subsequent signal transduction and activation of immunocompetent T lymphocytes. Because CD3 is required for T cell activation, drugs (often monoclonal antibodies) that target it are being investigated as immunosuppressant therapies (e.g., otelixizumab, teplizumab) for type 1 diabetes and other autoimmune diseases.

  • 流式分析

    • Flow cytometric analysis of human PBMC (human peripheral blood mononuclear cell) labelling Human CD3ε antibody at 1/2000 (0.1 μg) dilution (Right) compared with a Mouse monoclonal IgG isotype control (Left). Goat Anti - Mouse IgG Alexa Fluor® 488 was used as the secondary antibody. Then cells were stained with CD19 - Brilliant Violet 421™ separately. Events were gated on viable lymphocytes.